Latest Production News

Minbos Resources has launched a prospectus offering nearly 118 million free attaching options to recent Placement investors, aiming to bolster funding for its Cabinda fertilizer plant amid operational and geopolitical challenges in Angola.

Vintage Energy has signed a formal agreement to acquire Metgasco's 25% interest in the Southern Flank joint ventures for $5.9 million, advancing its strategic position in key gas assets.

Korab Resources reports significant gold and base metals exploration progress at its Rum Jungle Project, alongside innovative mining method evaluations and ongoing legal challenges to key lease renewals.

Lithium Energy Limited’s re-assay of 125 historical rock chip samples confirms significant high-grade gold mineralisation at Mt Usher, Queensland, unlocking promising exploration potential within the Capricorn Gold-Copper Belt Project.

Robex Resources has reached a pivotal milestone at its Kiniéro Gold Project in Guinea by delivering first ore to the mill, setting the stage for first gold production expected this month.

Medallion Metals has completed a Feasibility Study for its Ravensthorpe Gold Project, confirming robust economics and a clear pathway to near-term gold and copper production leveraging existing infrastructure in Western Australia.

Estrella Resources has reported outstanding high-grade manganese assay results from its Ira Miri prospect in Timor-Leste, with grades reaching as high as 58% manganese and strong continuity across multiple drill holes. These findings reinforce the project’s potential as a significant sedimentary manganese deposit.

ABx Group has secured a new five-year exploration licence in northern Tasmania, expanding its rare earths tenure between key deposits and advancing its high-value rare earth product development.

WIN Metals has raised A$5.5 million through a heavily oversubscribed placement to fund drilling and development at its Radio Gold Mine and Butchers Creek projects, aiming to fast-track gold production.

4DMedical has locked in $30.2 million through an underwriting agreement ensuring full exercise of its listed options, lifting its cash reserves to $63.7 million and setting the stage for a pivotal year in commercialising its CT – VQ™ technology.

Acrux Limited has sold the US registration and distribution rights for its Prilocaine 2.5% and Lidocaine 2.5% cream for US$550,000, redirecting resources towards its growing Hormone Replacement Therapy portfolio.

HITIQ has secured a prestigious grant from the Australian Sports Commission to enhance its PROTEQT™ brain health monitoring technology, positioning the company for wider adoption across elite and community sports.